Patrick F. Belcastro, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Patrick F. Belcastro, PhD
Dec 1, 2008

Patrick F. Belcastro, PhD is a Pharmtech editorial advisory board (EAB) member

Patrick F. Belcastro, PhD
Professor Emeritus,
School of Pharmacy,
Purdue University

Patrick F. Belcastro is professor emeritus of pharmaceutics in the department of industrial and physical pharmacy at Purdue University. He received an MS and PhD degree from Purdue University’s School of Pharmacy and Pharmaceutical Sciences.

His published articles, appearing in various professional and scientific periodicals, cover a wide variety of subject areas, including studies on the effects of x-radiation on the intestinal absorption and thyroid uptake of radioactive iodine-131, the effect of ultrasonic energy on the particle size of suspended pharmaceuticals, and other areas. Belcastro has served as a member of the editorial advisory board of Pharmaceutical Technology since 1977. He is a member of the American Pharmaceutical Association and the American Institute of the History of Pharmacy.

Over the years, Belcastro has taught a wide variety of graduate and undergraduate courses including those involving the manufacture and compounding of parenteral solutions. He has directed graduate studies of doctoral students at Purdue University, where he currently teaches an elective undergraduate course. He has also served as a member of the faculty at Duquesne University and at Ohio State University.

ADVERTISEMENT

post a comment
Please complete the form below to post your comment.
Bold = Required
Email Address Your email address will NOT be published.
Display Name appears with your comment
City
State
Country
Remember me: YesNo
Comment read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of active pharmaceutical ingredients?
The global economic recovery
The US economic recovery
Improved credit and financing flow to the small to emerging pharma/bio sector
Less restrictive inventory control by pharmaceutical companies
The level of competition from contract manufacturers in emerging markets
The global economic recovery
39%
The US economic recovery
14%
Improved credit and financing flow to the small to emerging pharma/bio sector
15%
Less restrictive inventory control by pharmaceutical companies
8%
The level of competition from contract manufacturers in emerging markets
24%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani EU pricing dilemmas
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
Keep an eye on that cargo
Pharma packs a punch
Another Boost for Vaccines
Rodney Dangerfield and R&D
Federal Spending Freeze Could Threaten Supply-Chain Security

FindPharma Custom Search
Featured Jobs

More Jobs

12/1/2008
Click here